Tramadol effects on physical performance and sustained attention during a 20-min indoor cycling time-trial: A randomised controlled trial

Holgado, Darias and Zandonai, Thomas and Zabala, Mikel and Hopker, James G. and Perakakis, Pandelis and Luque-Casado, Antonio and Ciria, Luis and Guerra-Hernandez, Eduardo and Sanabria, Daniel (2017) Tramadol effects on physical performance and sustained attention during a 20-min indoor cycling time-trial: A randomised controlled trial. Journal of Science and Medicine in Sport, . ISSN 1440-2440. E-ISSN 1878-1861. (doi:https://doi.org/10.1016/j.jsams.2017.10.032) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided)

PDF - Author's Accepted Manuscript

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Download (234kB) Preview
[img]
Preview
MS Office Open XML (OOXML) - Author's Accepted Manuscript
Restricted to Repository staff only
Contact us about this Publication Download (91kB)
[img]
Official URL
https://doi.org/10.1016/j.jsams.2017.10.032

Abstract

Objectives: To investigate the effect of tramadol on performance during a 20-min cycling time-trial (Experiment 1), and to test whether sustained attention would be impaired during cycling after tramadol intake (Experiment 2). Design: randomized, double-blind, placebo controlled trial. Methods: In Experiment 1, participants completed a cycling time-trial, 120-min after they ingested either tramadol or placebo. In Experiment 2, participants performed a visual Oddball task during the time-trial. Electroencephalography measures (EEG) were recorded throughout the session. Results: In Experiment 1, average time-trial power output was higher in the tramadol vs. placebo condition (tramadol: 220 watts vs. placebo: 209 watts; p < 0.01). In Experiment 2, no differences between conditions were observed in the average power output (tramadol: 234 watts vs. placebo: 230 watts; p > 0.05). No behavioural differences were found between conditions in the Oddball task. Crucially, the time frequency analysis in Experiment 2 revealed an overall lower target-locked power in the beta-band (p < 0.01), and higher alpha suppression (p < 0.01) in the tramadol vs. placebo condition. At baseline, EEG power spectrum was higher under tramadol than under placebo in Experiment 1 while the reverse was true for Experiment 2. Conclusions: Tramadol improved cycling power output in Experiment 1, but not in Experiment 2, which may be due to the simultaneous performance of a cognitive task. Interestingly enough, the EEG data in Experiment 2 pointed to an impact of tramadol on stimulus processing related to sustained attention. Trial registration: EudraCT number: 2015-005056-96.

Item Type: Article
Uncontrolled keywords: Doping in sport, Opioid analgesic, Athletes, EEG, Exercise, Brain
Subjects: R Medicine > RC Internal medicine > RC1200 Sports Medicine
R Medicine > RC Internal medicine > RC1235 Physiology of sports
Divisions: Faculties > Sciences > School of Sport and Exercise Sciences
Depositing User: James Hopker
Date Deposited: 10 Nov 2017 16:08 UTC
Last Modified: 07 Nov 2018 00:00 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/64187 (The current URI for this page, for reference purposes)
  • Depositors only (login required):

Downloads

Downloads per month over past year